Combined rifampicin and chloramphenicol therapy for Enterobacter osteomyelitis.
A 2-month-old infant with Enterobacter osteomyelitis complicating total parenteral nutrition was successfully treated with rifampicin and chloramphenicol. No untoward side effects attributed to rifampicin has been noted despite prolonged administration of rifampicin.
D002701:Chloramphenicol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004754:Enterobacter; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007223:Infant; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy* / Q000209:etiology; D010288:Parenteral Nutrition / Q000009:adverse effects*; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*
D002701:Chloramphenicol; D012293:Rifampin